Trial intelligence / Profile preview

Exenatide in Type 1 Diabetes Mellitus

NCT00456300Phase 2Completed

Sponsor
Montefiore Medical Center
Start
Mar 2007
Primary completion
Mar 2009
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of exenatide in type 1 diabetes mellitus (T1D), sponsored by Montefiore Medical Center. Started Mar 2007; status: completed.

02

Drugs

exenatide
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00456300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00456300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call